99.42%COA›
GLP-1 & Metabolic
AP2-T
Purity 99.90%Min 10 vials per SKU (1 kit)
$22.00$30.80
1 kit — $220.00 per kit (10 vials).
Select dose
Select kit quantity
All vial caps are white and flip-off.
Third-party tested
HPLC + MS verified on every production lot.
Same day shipping
All orders received by 2PM ship the same day.
COA on request
Lot documentation available for every compound.
AP2-T (Tirzepatide) is supplied in 10 mg vials, packed 10 vials per kit (1 SKU minimum). CAS 2023788-19-2. Purity 99.34% by HPLC.
Description
AP2-T is our designation for research-grade tirzepatide, a dual GIP/GLP-1 receptor agonist. Supplied lyophilized in 10-vial kits, 99%+ purity by third-party HPLC and mass spectrometry, COA available per lot.
What is Tirzepatide?
Tirzepatide is a 39-amino-acid synthetic peptide built on a GIP backbone with a fatty-acid moiety for extended action, engaging both GIP and GLP-1 receptors from one molecule.
Key research applications
Dual-agonist pharmacology
Investigating how combined GIPR and GLP-1R activation differs from single-receptor stimulation.
Energy-balance models
Used in adiposity, food-intake, and thermogenesis endpoints.
Glycemic research
Applied to insulin secretion, glucagon suppression, and glucose-tolerance assays.
Lipid endpoints
Studied for triglyceride and hepatic fat measures in preclinical work.
AP2-T specifications
- Amount
- 10 mg | 20 mg | 30 mg | 60 mg per vial · 10 vials per kit
- Purity
- 99.34%+ (third-party HPLC and mass spectrometry)
- Formula
- C225H348N48O68 | MW: ≈4,813 Da | CAS: 2023788-19-2
- Form
- Lyophilized powder
- Storage
- -20°C or below as a lyophilized powder; 2-8°C after reconstitution and used within the window defined by your protocol.
- Testing
- Lot PX1T10-0021 — COA-2026-SFWEND, 99.90% purity by HPLC, tested 09/09/2026 by an independent ISO/IEC 17025 lab
- Origin
- US manufactured, third-party tested
- Presentation
- White flip-off caps on every vial
Research use only. Not for human or veterinary consumption, diagnostic, or therapeutic use.